Manufacture and Supply of BenzoCaine Gel (OTC Topical Anesthetic)

The contract entails the manufacture and supply of a 10 percent benzocaine gel, USP, packaged in 7.5-gram tubes with a formulation containing 65 percent alcohol by volume, intended for over-the-counter topical anesthetic use by military medical personnel. The product must fully comply with both over-the-counter labeling requirements and current good manufacturing practices to ensure safety, efficacy, and consistency for military healthcare applications. All deliverables must meet stringent quality and regulatory standards appropriate for federal medical procurement, with the product destined for performance at a military postal address designated as FPO, ZIP 96667. The solicitation, issued under the NAICS code 325412 for pharmaceutical preparation manufacturing, is structured as a subcontract and was posted on May 11, 2026, with responses due by May 18, 2026. The contracting activity is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, indicating this is a critical supply need within the military’s pharmaceutical logistics network. There is no set-aside designation applied, and the procurement is open to qualified manufacturers capable of meeting the technical, regulatory, and delivery specifications outlined in the solicitation. Interested parties must respond through the official DIBBS platform linked in the posting.